Bausch Health Companies (BHC) Change in Receivables (2009 - 2026)

Bausch Health Companies (BHC) has 18 years of Change in Receivables data on file, last reported at -$148.0 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Receivables fell 34.55% year-over-year to -$148.0 million; the trailing twelve-month figure through Mar 2026 stood at $96.0 million (up 123.26% YoY), and the FY2025 full-year result was $134.0 million, down 37.96% from the prior year.
• Change in Receivables retreated to -$148.0 million in Q1 2026, from -$65.0 million in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $231.0 million in Q3 2023 to a low of -$197.0 million in Q1 2022.
• A 5-year average of $26.7 million and a median of $53.0 million in 2023 frame the typical range for Change in Receivables.
• Peak annual rise in Change in Receivables reached 1047.83% in 2025, while the deepest fall reached 274.6% in 2025.
• Tracing BHC's Change in Receivables over 5 years: stood at $31.0 million in 2022, then sank by 38.71% to $19.0 million in 2023, then soared by 447.37% to $104.0 million in 2024, then tumbled by 162.5% to -$65.0 million in 2025, then sank by 127.69% to -$148.0 million in 2026.
• Business Quant data shows BHC's Change in Receivables at -$148.0 million in Q1 2026, -$65.0 million in Q4 2025, and $218.0 million in Q3 2025.